Atezolizumab for First-Line Treatment of PD-L1–Selected Patients with NSCLC

Authors: Roy S. Herbst, Giuseppe Giaccone, Filippo de Marinis, Niels Reinmuth, A. Vergnenègre et al.

Year: 2020

AtezolizumabMedicineOncologyInternal medicineLung cancer